CERT1 and neoplasm: Fewer GPBP−/− mice developed tumors (24% in GPBP−/−, 76% in WT) or lung metastases (25% in GPBP−/−, 62% in WT), demonstrating that deficiency of host GPBP also reduced tumor load.